<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-pharmaceutics-12-00688">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hsu</surname>
    <given-names>C.Y.</given-names>
   </name>
   <name>
    <surname>Sung</surname>
    <given-names>C.T.</given-names>
   </name>
   <name>
    <surname>Aljuffali</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>K.Y.</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>J.Y.</given-names>
   </name>
  </person-group>
  <article-title>Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia</article-title>
  <source>Nanomedicine</source>
  <year>2018</year>
  <volume>14</volume>
  <fpage>215</fpage>
  <lpage>225</lpage>
  <pub-id pub-id-type="doi">10.1016/j.nano.2017.10.006</pub-id>
  <?supplied-pmid 29128664?>
  <pub-id pub-id-type="pmid">29128664</pub-id>
 </element-citation>
</ref>
